Digital Mammographic Imaging Screening Trial

The Digital Mammographic Imaging Screening Trial (DMIST), is a multi-institutional research study on the efficacy for screening of Full Field digital mammography compared to conventional film-screen mammography that was sponsored by the U.S. National Cancer Institute and performed by ACRIN.

The findings[1][2] that FFDM was not inferior to the existing technology, and potentially superior in younger women with dense breasts, has led to a rapid proliferation of digital systems in the US.

References

  1. ↑ Pisano (27 Oct 2005). "Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening". NEJM. Retrieved 11 Feb 2010.
  2. ↑ Berry (27 Oct 2005). "Film or Digital Mammographic Screening?". NEJM. Retrieved 11 Feb 2010.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.